Surprising new roles for endothelinsBMJ 1996; 312 doi: http://dx.doi.org/10.1136/bmj.312.7025.195 (Published 27 January 1996) Cite this as: BMJ 1996;312:195
- Albert C M Ong
- National Kidney Research Fund senior fellow MRC Molecular Haematology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DJ
Mutant mice reveal the first clear links to human disease
The use of so called “knockout” mice in scientific research continues to produce surprises. Deficient in a particular molecule as a result of targeted mutagenesis, they allow scientists to study the essential physiological role of the absent molecule. Such has been the case with the endothelins, vasoactive peptide mediators whose discovery in 1988 was a highpoint in vascular biology.1 Humans have three endothelin isoforms, endothelins 1,2, and 3,2 and two endothelin receptor subtypes, endothelins A and B, whose functions remain to be completely elucidated.
Endothelin-1 is the most potent vasoconstrictor substance yet described,1 and the major focus in endothelin research has been to investigate its role in the regulation of normal systemic and regional vascular tone.2 In the intense research activity that followed discovery of endothelin-1 it soon became apparent that endothelins did not function as classical circulating humoral factors, but rather as locally acting autocrine or paracrine factors. Surprisingly, the endothelins were also found to be synthesised by a variety …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial